Results 151 to 160 of about 1,072 (198)
Black cohosh (Cimicifuga racemosa): a systematic review of adverse events
Black cohosh (Cimicifuga racemosa) is used most often to treat symptoms that can occur during menopause. However, in the last years, several concerns regarding its safety have been voiced.
Francesca Borrelli
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Antiestrogenic activities of Cimicifuga racemosa extracts
The Journal of Steroid Biochemistry and Molecular Biology, 2002Despite the wide use of extracts from the rhizome of black cohosh (Cimicifuga racemosa) for the treatment of menopausal complaints, surprisingly little is known on their potential estrogenic properties, e.g. on estrogen dependent gene transcription. In addition, available informations on the effects on cell proliferation are contradictory. We therefore,
Oliver, Zierau +4 more
openaire +2 more sources
SOMATIC EMBRYOGENESIS IN CIMICIFUGA RACEMOSA
Acta Horticulturae, 2007Since a long time Cimicifuga has been used for therapeutic purposes. The demand for the plant drug Cimicifugae rhizoma has been increased tremendously during the last years. This study aimed to develop a method for somatic embryogenesis in Cimicifuga.
I. Pinker, R. Schenk
openaire +1 more source
Das Phytotherapeutikum Cimicifuga racemosa (Traubensilberkerze)
Deutsche Zeitschrift für Onkologie, 2022ZusammenfassungFrauen mit Brustkrebs leben oft mit erheblichen Nebenwirkungen einschließlich der Einleitung einer frühen Menopause, die u. a. zu vasomotorischen Symptomen, Stimmungsschwankungen und muskuloskelettalen Schmerzen führt.
openaire +1 more source
The safety of black cohosh (Actaea racemosa, Cimicifuga racemosa)
Expert Opinion on Drug Safety, 2004Black cohosh (Actaea racemosa/Cimicifuga racemosa) is a North American perennial plant that has been used for traditional medicinal purposes by the native Indian population. Its modern day application is the treatment of menopausal symptoms. Unlike conventional non-herbal medications, herbal preparations have not been systematically evaluated for their
openaire +2 more sources
Triterpenoid glycoside from Cimicifuga racemosa
Journal of Asian Natural Products Research, 2005One new triterpene glycoside, cimiracemoside , and 14 known triterpene glycosides have been isolated from the rhizome extracts of black cohosh (Cimicifuga racemosa). On the basis of spectral and chemical evidence, the structure of the new compound was elucidated to be 12beta-acetoxycimigenol-3-O-beta-D-xylopranoside, and the known compounds were ...
G F, Lai +4 more
openaire +2 more sources
Triterpene Glycosides from Cimicifuga racemosa
Journal of Natural Products, 2000Eight new triterpene glycosides named cimiracemosides A-H, respectively, and eight known triterpene glycosides were isolated from the rhizome extracts of black cohosh (Cimicifuga racemosa). The new compounds were determined by spectral data to be 21-hydroxycimigenol-3-O-alpha-L-arabinopyranoside (1), 21-hydroxycimigenol-3-O-beta-D-xylopyranoside (2 ...
Y, Shao +6 more
openaire +2 more sources
Muscle damage induced by black cohosh (Cimicifuga racemosa)
Phytomedicine, 2006Extracts of black cohosh (Cimicifuga racemosa) are commonly used for the treatment of symptoms associated with menopause. Adverse events with black cohosh are rare, mild and reversible. A few number of serious adverse events, including hepatic and circulatory conditions, have been also reported, but without a clear causality relationship. We report the
MINCIULLO, PAOLA LUCIA +5 more
openaire +3 more sources
Cimiracemates A—D, Phenylpropanoid Esters from the Rhizomes of Cimicifuga racemosa
ChemInform, 2002AbstractFor Abstract see ChemInform Abstract in Full Text.
Shao-Nong, Chen +5 more
openaire +2 more sources
Cutaneous pseudolymphoma induced by Cimicifuga racemosa.
Dermatology (Basel, Switzerland), 2007We report a 56-year-old female patient who presented with asymptomatic, localized erythematous plaques on arms and legs. Histologically, the diagnosis of pseudolymphoma (PL) was confirmed. Because of menopausal complaints, the patient had been taking Remifemin(R), a phytotherapeutical agent containing a standardized extract of black cohosh (Cimicifuga ...
S, Meyer +4 more
openaire +1 more source

